Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RALLY-IBD: A Phase 2 Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Efficacy of DISC-0974 in Participants With Inflammatory Bowel Disease and Anemia of Inflammation

NCT07368972 is registered in ClinicalTrials.gov with Disc Medicine, Inc as lead sponsor.

NCT NCT07368972
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07368972 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RALLY-IBD: A Phase 2 Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Efficacy of DISC-0974 in Participants With Inflammatory Bowel Disease and Anemia of Inflammation
Lead sponsor
Disc Medicine, Inc
Phase
Phase 2
Overall status
Recruiting
Start date
February 20, 2026
Completion date
March 31, 2027
Enrollment
21 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, inflammatory bowel disease (ibd), inflammatory bowel disease (ibd); anemia